Other Treatments

Some prostate cancer treatments don’t fall neatly into a category such as “radiation therapy” or “hormone therapy.” These include high-intensity focused ultrasound (HIFU), an investigational treatment that uses sound waves to destroy cancerous tissue, and cryotherapy, which kills cancer cells by freezing them. For cases of advanced, metastatic disease, your doctor may recommend chemotherapy or the recently approved prostate cancer “vaccine.”

Related Articles

Treatment versus monitoring of prostate cancer: Survival rates the same after 10 years

Charles Schmidt A pair of new studies provides useful information to men facing challenging decisions about what to do after being diagnosed with early prostate cancer. Researchers tracked men for 10 years and found that virtually none died of the illness, even if they decided against treating it. Early prostate tumors confined to the prostate […]

Read more »

Promising results for a targeted drug in advanced prostate cancer

It’s well known that defective BRCA genes can increase a woman’s chances of developing breast, ovarian, and other cancers. But these same gene changes can also increase a man’s risk of dying from prostate cancer. Now, a new study published in The New England Journal of Medicine has shown that men with prostate cancer who […]

Read more »

FDA panel rejects high intensity focused ultrasound for early prostate cancer

An FDA advisory panel rejected a French company’s application to market high intensity focused ultrasound as a treatment for localized prostate cancer.

Read more »

Delaying treatment for PSA-only relapse poses won’t hurt survival in some men

Men who experience a spike in PSA but who have no symptoms after surgery or radiation therapy for prostate cancer can wait for up to two years before starting hormone therapy, according to a new study.

Read more »

Heart drug may fight prostate cancer

Digoxin (Lanoxin), a drug long used to treat heart failure and heart rhythm abnormalities, may control prostate cancer.

Read more »

FDA approves abiraterone for advanced prostate cancer

The drug, approved at the end of April 2011, may be helpful for men with metastatic disease that no longer responds to hormone therapy.

Read more »

Experimental drug seems safe, effective against prostate cancer

A study published in the journal Lancet found that the experimental drug MDV3100 is both safe and effective for prostate cancer patients with advanced disease that no longer responds to hormone therapy.

Read more »

Prostate cancer vaccine approved by the FDA

Sipuleucel-T (Provenge), a “vaccine” that uses a patients immune system to fight advanced stage disease, was approved by the FDA in April 2010. The vaccine does not prevent cancer; rather, it helps men with advanced stage, hormone-resistant disease live longer.

Read more »

HIFU controls recurrent cancer in short run

Researchers find that high-intensity focused ultrasound (HIFU) may be effective in treating localized recurrent prostate cancer while also minimizing the chances of side effects.

Read more »

Experimental therapies for prostate cancer

Androgen deprivation, whether through surgical removal of the testicles or with medication, is an effective treatment for recurring prostate cancer — at least for a while. An improved understanding of the biology of prostate cancer has led to the development of two drugs that might slow disease progression in prostate cancer patients whose disease no longer responds to androgen deprivation.

Read more »